Fuse Medical, Inc.
Datakwaliteit: 100%
FZMD
OTC
Wholesale Trade
Durable Goods Wholesale
€ 0,02
€ 0,00
(0,00%)
Marktkapitalisatie: 1,48 M
Prijs
€ 0,02
Marktkapitalisatie
1,48 M
Dagbereik
€ 0,02 — € 0,02
52-Weeksbereik
€ 0,02 — € 0,10
Volume
142.040
Openen € 0,02
50D / 200D Gem.
€ 0,04
46,81% below
50D / 200D Gem.
€ 0,06
67,53% below
Quick Summary
Belangrijkste Punten
Revenue declined -8,28% annually over 5 years
Net margin of 19,72% shows strong profitability
Generating 18.641,0 in free cash flow
P/E of 0,41 — trading at a low valuation
Groei
Revenue Growth (5Y)
-8,28%
Onder sectorgemiddelde (257,90%)
Revenue (1Y)-8,67%
Earnings (1Y)N/A
FCF Growth (3Y)-59,85%
Kwaliteit
Return on Equity
N/A
ROIC-3,30%
Net Margin19,72%
Op. Margin-1,30%
Veiligheid
Debt / Equity
N/A
Current Ratio1,06
Interest Coverage-1,13
Waardering
PE (TTM)
0,41
Boven sectorgemiddelde (-27,54)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Wholesale Trade sector mediaan (3 peers)
Sectorvergelijking
vs Wholesale Trade sector mediaan (3 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,4 | -27,5 |
| P/B | — | 1,6 |
| ROE % | — | -2,8 |
| Net Margin % | 19,7 | -199494,9 |
| Rev Growth 5Y % | -8,3 | 257,9 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -8,67% | Revenue Growth (3Y) | -6,66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8,28% | Earnings Growth (5Y) | -5,94% |
| Profitability | |||
| Revenue (TTM) | 18,40 M | Net Income (TTM) | 3,63 M |
| ROE | N/A | ROA | 19,23% |
| Gross Margin | 64,95% | Operating Margin | -1,30% |
| Net Margin | 19,72% | Free Cash Flow (TTM) | 18.641,0 |
| ROIC | -3,30% | FCF Growth (3Y) | -59,85% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,06 |
| Interest Coverage | -1,13 | Asset Turnover | 0,98 |
| Working Capital | 754.339 | Tangible Book Value | -3,33 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0,41 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 0,08 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1,26% | ||
| Market Cap | 1,48 M | Enterprise Value | 1,22 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,04 | Revenue / Share | 0,25 |
| FCF / Share | 0,00 | OCF / Share | -0,01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | -9,64% |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 0,51% |
| SBC-Adj. FCF | 1.649 | Growth Momentum | -0,39 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | 18,64 M | 20,41 M | 21,40 M | 22,90 M | 26,34 M |
| Net Income | 3,10 M | -1,59 M | -1,43 M | -3,32 M | 3,96 M |
| EPS (Diluted) | 0,04 | -0,02 | -0,02 | -0,05 | 0,06 |
| Gross Profit | 11,54 M | 11,94 M | 12,70 M | 11,14 M | 12,99 M |
| Operating Income | -815.072,0 | -2,20 M | -1,03 M | -4,35 M | -1,96 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 6,54 M | 7,01 M | 6,54 M | 8,47 M | 8,47 M |
| D&A | 137.403,0 | 67.638,0 | 104.143,0 | 107.073,0 | 49.685,0 |
| Interest Expense | 171.294,0 | 78.230,0 | 94.953,0 | 121.633,0 | 133.944,0 |
| Income Tax | 23.655,0 | 17.723,0 | 18.993,0 | 781.085,0 | -386.784,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Total Assets | 19,76 M | 18,30 M | 17,42 M | 18,38 M | 22,17 M |
| Total Liabilities | 20,07 M | 21,74 M | 19,53 M | 19,60 M | 20,71 M |
| Shareholders' Equity | -310.854,0 | -3,43 M | -2,11 M | -1,22 M | 1,47 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 147.854,0 | 553.190,0 | 1,19 M | 1,10 M | 844.314,0 |
| Current Assets | 13,77 M | 12,82 M | 12,62 M | 15,17 M | 17,18 M |
| Current Liabilities | 12,39 M | 9,94 M | 7,25 M | 7,96 M | 7,12 M |
{"event":"ticker_viewed","properties":{"ticker":"FZMD","listing_kind":"stock","pathname":"/stocks/fzmd","exchange":"OTC","country":"US"}}